INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
10/06/2026
Voltar para busca
Dado oficial do USPTO
G GNA BIOSOLUTIONS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
42
Atualização mais recente
11/06/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 9, 10, 42
Data de depósito
28/07/2017
Data de registro
26/03/2019
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
10/10/2025
Última transação
11/06/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
5
Tipo de titular
27
Localização do titular
DE
Examinador
THOMAS, JULIE
Unidade examinadora
L70
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of "G GNA BIOSOLUTIONS" in stylized font.
Titulares e representantes
Titulares
GNA Biosolutions GmbH
Representantes
Jacqueline Zion Pearl Cohen Zedek Latzer Baratz LLP
Classificação técnica
Classes Nice
Classe 5Classe 9Classe 10Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Diagnostic chemical reagents for medical use; chemical reagents for medical or veterinary purposes; diagnostic preparations for medical purposes; diagnostic agents for pharmaceutical use; diagnostic preparations for veterinary purposes; diagnostic biomarker reagents for medical purposes; diagnostic testing materials for medical use testing of the intended performance characteristics of bioanalytical methods; diagnostic reagents for medical use; clinical medical reagents; reagents for in-vitro laboratory use for medical purposes; reagents for in-vitro laboratory use for veterinary purposes; reagents for microbiological analysis for medical purposes; reagents for microbiological analysis for veterinary purposes; reagents for use in diagnostic tests for medical purposes; reagents for use with analyzers for veterinary purposes; reagents for use with analyzers for medical purposes
Classe 9
Biochips for research or scientific purposes; diagnostic apparatusnot for medical purposesfor bioanalytical purposesin particular for nucleic acid amplification and detection; computer software applicationsdownloadablefor setting upconductinginterpretingstoring bioanalytical measurementsin particular for nucleic acid amplification and detection; lasersnot for medical purposes; chemistry apparatus and instrumentsfor bioanalytical procedures; recorded computer programs for setting upconducting interpretingstoring bioanalytical measurementsin particular for nucleic acid amplification and detection; downloadable computer software programs for setting upconductinginterpretingstoring bioanalytical measurementsin particular for nucleic acid amplification and detection; recorded computer software for setting upconductinginterpretingstoring bioanalytical measurementsin particular for nucleic acid amplification and detection; DNA chips; air analysis apparatus; optical apparatus and instrumentsfor bioanalytical measurements; laboratory equipmenttest tubes; probes for scientific purposes for conducting bioanalytical measurementsin particular for nucleic acid amplification and detection; scientificelectrotechnicalelectronicopticalmeasuringsignalingcheckingsupervision apparatus and instrumentsfor conducting bioanalytical proceduresin particular sample preparationnucleic acid amplification and detection; laboratory apparatusanalysis apparatus and parts thereforfor conducting bioanalytical proceduresin particular sample preparationnucleic acid amplification and detection; scanners; laboratory equipmentin particular apparatus for bioanalysisin particular temperature cyclersfluorescence scanners and apparatuses for nucleic acid amplification and detectionin particular using a cartridge for preparing samplespurifying nucleic acids and amplifying nucleic acids and for detecting nucleic acids; disposable articles for laboratory apparatusin particular sample and receptaclesmainly consisting of plastic; parts and fittings for all the aforesaidmechanicalelectricalstructural modules or components
Classe 10
Apparatus for DNA and RNA exams for medical purposes; blood testing apparatus; diagnostic apparatus for medical purposes for detecting target molecules of interest in a samplein particular a patient sample; lasers for medical purposes; medical apparatusin particular apparatus for bioanalysisthe extractionamplificationdetection of target molecules of interest; diagnostic apparatus for veterinary purposes for detecting target molecules of interest; automatic analyzers for medical diagnosis for detecting target molecules of interest; medical apparatus and instrumentsfor detecting target molecules of interest; medical instruments for infectious disease testinghuman or veterinary pathogens; medical and veterinary apparatus and instrumentsfor processing samplesdetecting target molecules of interest; tools for veterinary diagnosticsdetecting target molecules of interest
Classe 42
Updating of computer software; maintenance of software; biological research; cloud computing featuring software for setting upconductinginterpretingstoring bioanalytical measurementsin particular for nucleic acid amplification and detection; chemical laboratories; chemical analysis; bacteriological research; chemical research; research and development of new products for others; conducting clinical trials for others for scientific and medical research; medical and scientific research services; scientific laboratory services; clinical laboratory services for scientific purposes; scientific and technological services and research and design relating theretoconducting bioanalytical procedures; industrial analysis and research servicesconducting bioanalytical proceduresin particular nucleic acid amplification and detection for scientific research purposes; design and development of computer hardware and software; scientific analysis of cellsproteinsnucleic acids and other molecules between 50 and 10 000 daltonsfor DNA sequencing and genotypingfor detecting DNS mutationsfor gene expression profilingin particular relating to the conducting of high throughput screening methods; information and advice relating to the aforesaid services; development and conducting of scientific analyses and diagnostic methodsfor others
Publicações
Histórico de despachos e eventos da marca no USPTO.
42 publicações encontradas
C71T
CANCELLED SECTION 71
10/10/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
26/03/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
09/10/2020
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
16/08/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
25/07/2019
FIMP
FINAL DISPOSITION PROCESSED
25/07/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
26/06/2019
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
05/04/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
26/03/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
20/03/2019
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
20/03/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/01/2019
PUBO
PUBLISHED FOR OPPOSITION
08/01/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
19/12/2018
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
30/11/2018
ALIE
ASSIGNED TO LIE
29/11/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/11/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
08/11/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/11/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
08/11/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/11/2018
RFNP
REFUSAL PROCESSED BY IB
06/10/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/08/2018
GNRT
NON-FINAL ACTION E-MAILED
07/08/2018
CNRT
NON-FINAL ACTION WRITTEN
07/08/2018
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
09/07/2018
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
26/06/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/06/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
24/05/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
23/05/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
23/05/2018
NREP
NEW REPRESENTATIVE AT IB RECEIVED
23/03/2018
RFNT
REFUSAL PROCESSED BY IB
17/12/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
28/11/2017
RFRR
REFUSAL PROCESSED BY MPU
28/11/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
15/11/2017
CNRT
NON-FINAL ACTION WRITTEN
14/11/2017
MAFR
APPLICATION FILING RECEIPT MAILED
31/10/2017
DOCK
ASSIGNED TO EXAMINER
28/10/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
25/10/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
19/10/2017
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace G GNA BIOSOLUTIONS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.